Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 8,986 | 4,366 | 31 | 40 | 44 |
| Gross Profit | 8,986 | 4,366 | 31 | 40 | 44 |
| Operating Expenses | 15,116 | 19,267 | 21,826 | 19,381 | 21,309 |
| Operating Income | -6,130 | -14,902 | -21,795 | -19,342 | -21,265 |
| Other Income | 87 | 2,816 | -425 | -79 | 449 |
| Pre-tax Income | -6,043 | -12,086 | -22,220 | -19,421 | -20,816 |
| Net Income Continuous | -6,043 | -12,086 | -22,217 | -19,421 | -20,816 |
| Net Income | $-6,043 | $-12,086 | $-22,222 | $-19,421 | $-20,816 |
| EPS Basic Total Ops | -0.08 | -0.17 | -0.35 | -0.32 | -0.35 |
| EPS Basic Continuous Ops | -0.08 | -0.17 | -0.34 | -0.32 | -0.35 |
| EPS Diluted Total Ops | -0.08 | -0.17 | -0.35 | -0.32 | -0.35 |
| EPS Diluted Continuous Ops | -0.08 | -0.17 | -0.34 | -0.32 | -0.35 |
| EBITDA(a) | $-5,006 | $-13,716 | $-20,921 | $-18,501 | $-20,390 |